SeaStar Medical stockholders approve tripling of equity plan shares and warrant issuance to institutional investor

SeaStar Medical Holding Corp

Elected directors Collins, Baird, Vincent with >25M votes each; no director received majority against.
Approved amendment to 2022 Omnibus Plan increasing authorized shares from 3,278,457 to 9,778,457.
Approved issuance of 20%+ of outstanding shares upon exercise of Series A (10.8M) and Series B (5.4M) warrants to a single institutional investor.
Ratified WithumSmith+Brown as independent auditor for FY2024 with 44.6M for, 1.8M against.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.